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Mitochondrial diseases are a plethora of oxidative phosphoryla-
tion (OXPHOS) related disorders, which have an estimated preva-
lence of, 1:5000 in children and 1:10,000 in adults. Mitochondrial
disorders in adulthood generally are caused by mutations in the
mitochondrial DNA (mtDNA), whereas pediatric disorders are often
associated with nuclear DNA (nDNA) mutations. The inheritance of
these disorders, could be maternal or mendelian depending on the
origin, if the mutation is in the mtDNA or nDNA respectively [1,2].
Most mitochondrial functions, including aerobic ATP production,
require an inside negative potential (Δψ) across the mitochondria
inner membrane (MIM). This Δψ is sustained by the action of the
electron transport chain (ETC), which together with the ATP-
synthesizing F0F1-ATPase, constitutes the oxidative phosphorylation
(OXPHOS) system. The ETC consists of four complexes (CI–CIV) of
which CI is the largest and least well understood. Importantly,
inherited mutations in nDNA-encoded CI subunits are the most
frequent cause of OXPHOS deﬁciency in humans. In this project we
use a knockout animal model with severe nDNA CI dysfunction,
displaying behavioral and pathophysiological changes leading to
disease symptoms and a lethal phenotype [3].
We analyzed the biochemical and metabolic consequences of this
dysfunction in tissues with high energy demand at the level of
substrate oxidation, ATP production and biochemical activities of the
respiratory chain complexes. Our ﬁndings indicate, that there is tissue
speciﬁc adaptation seen in the skeletal muscle and the heart, however
we do not observe the same adaptation in the brain. This leads us to
conclude that the brain is the most affected tissue due to CI
deﬁciency. We believe that our data will help in creating rational
mitigative strategies, which will be targeting the brain to treat this
fatal phenotype.
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Respiratory complex I is present in the three domains of life and
plays a central role in energy transduction. It catalyzes the oxidation
of NADH and reduction of quinones, coupled to cation translocation
across the membrane, thereby establishing an electrochemical
potential. It is a large enzyme composed by a peripheral and a
membrane part in an L-shaped assembly. This enzyme is an example
of the modular structure observed in several energy transducing
enzymes. The complex I from prokaryotes may be viewed as a
combination of 14 modules most of which identiﬁed in other
complexes, such as type 4 membrane-bound [NiFe] hydrogenases
and some subunits of Mrp Na+/H+ antiporters.
In this work we put forward a thorough taxonomic proﬁle of
prokaryotic type 4 membrane-bound [NiFe] hydrogenases, complex I
and complex I-like enzymes which have at least four common
subunits that we dominated as the universal adaptor (NuoH, L, B
and D). In addition we investigated the different gene clustering
organization of such complexes. We showed the presence of
complexes related to hydrogenases, named before Ehr (Energy-
converting hydrogenases related complexes), but which do not
contain the binding site of the catalytic centre (NiFe). These
complexes are a missing link between complex I and type 4
membrane-bound [NiFe]-hydrogenases. Based on our observation
we discuss the evolutionary, functional and mechanistic implications
of a different perspective for the relation between complex I and
related enzymes.
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NADH:quinone oxidoreductase (complex I) is the ﬁrst enzyme of
the respiratory chain and the entry point for NADH, a high energy
electron carrier. The mammalian complex consists of 45 subunits
with a combined mass of 980 kDa, whilst its highly conserved
bacterial homologue contains approximately 14 subunits with a mass
of 550 kDa. The prokaryotic enzyme still maintains the core
bioenergetics function and therefore represents a minimal model for
the mammalian enzyme. Complex I catalyses the reduction of
quinone to quinol by transferring electrons from NADH, via a series
of non-covalently bound prosthetic groups. The process of electron
transfer is coupled to proton translocation across the membrane
which establishes a proton motive force; the mechanism, however,
remains largely unknown.
Quinone is proposed to bind at the interface between the
hydrophilic and membrane domain. The present structure of complex
I from Thermus thermophilus [1] suggests that once quinone is bound
to the membrane domain, it has to move into the hydrophilic domain
by up to 20 Å, to be within close proximity of the N2 iron–sulphur
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